Doylestown Clinical Trials Hopewell | Hamilton Clinical Trials Trenton, New Hope

A clinical trial is a medical research study conducted to evaluate and answer specific questions about a potential treatment for use in patient care. Researchers conduct clinical trials to determine the safety and efficacy of new drugs or study the use of established drugs in new ways.

Clinical trials are meant to benefit future patients. They are performed to assess the potential value of a new therapy without offering proven results.

Clinical trials are never performed until careful scientific research has been conducted to indicate a potential benefit.

Participation in clinical trials is voluntary. Patients can discontinue participation at any time and it will not affect their relationship with their doctor(s) or employees involved in the study.

At MEA we stay current with the latest technology and are honored to be asked to participate in many clinical trials.

2004	Wills Eye Hospital – Internet Based Study, Is One of Two Topical Prostaglandin Analogues Significantly More Tolerable Than the Other: Bimatroprost v. Latanoprost?
2005 – 06	Alcon Pharmaceutical, Travatan dosing aid study
2007	Allergan, Inc. – Phase IV – A Multicenter, Masked Evaluation of Ocular Surface Tolerability Associated with Bimatoprost 0.03%, Travoprost 0.004% (BAK free) or Latanoprost 0.005% Therapy in Patients with Glaucoma or Ocular Hypertension.
2008	Ista Pharmaceuticals – Phase II – A Multi-Center, Double Blind, Vehicle-Controlled, Randomized Study of Ecabet Ophthalmic Solution in Patients with Dry Eye Disease
2008	Allergan, Inc. – Phase IV – A Multi-Center, investigator-masked, randomzed, parallel study to compare the IOP lowering efficacy and safety of Combigan (fixed combination of 0.2% Brimonidine Tartrte and 0.5% Timolol Maleate) with Timolol (0.5% Timolol Maleate), when each is used as adjunctive therapy to Xalatan (0.005% Latanoprost) in subjects with Open-Angle Glaucoma and Ocular Hypertension.
2009	Sanofi-Aventis – Providing ophthalmologic evaluations for a study in which Tamaris, a vascular endothelial growth factor, is being used to help peripheral blood vessels. The study requires dilated ophthalmic funduscopic exams to participants on scheduled intervals
2009	Ista Pharmaceuticals – Efficacy and Safety of Bromfenac Ophthalmic Solution QD vs. Placebo QD for Treatment of Ocular Inflammation and Pain Associated with Cataract Surgery
2010	Abbot Medical Optics – Evaluation of Blink® artificial tears on its effectiveness for the symptoms of dry eye syndrome
2010	Ista Pharmaceuticals – 6 Month Dry Eye Study
2011	Abbot Medical Optics – Evaluation of RevitalLens for soft contact lens care
2011	Alcon Pharmaceuticals – Difluprednate Ophthalmic Emulsion 0.05% for postoperative inflammation and pain QID vs BID when paired with an NSAID
2012	The use of an equibiconvex quarter diopter aspheric IOL for cataract surgery to measure uncorrected intermediate vision.
2012	Conversion rates for premium services (LRI, Toric and presbyopia correcting IOLs) based on gender and age.
2012	Mixing and matching a toric IOL in the eye with the greater astigmatism and using a blended mini-mono approach with an aspheric mono-focal IOL plus an LRI to correct the spherical and cylinder errors in the eye with the lesser astigmatism.
2013	The influence of the PRN Dry Eye Omega 3 nutritional regimen in osmolarity in cases of occasional dry eye.
2013	Impact of tear osmolarity on pre-surgical calculations in cataract surgery.
2013	SONATA, a Phase III, multi-center, randomized, double-masked and placebo-controlled study evaluating the safety of a 5.0% concentration of Lifitegrast Ophthalmic Solution compared to placebo in subjects with dry eye.